Safety, tolerability and pharmacokinetics of udenafil, a novel PDE‐5 inhibitor, in healthy young Korean subjects

Abstract

Udenafil was safe and well tolerated in healthy volunteers. The AUC and C(max) of udenafil increased supraproportionally with increasing dose upon single administration, but there was no significant drug accumulation upon multiple administrations.